Quinine Bisulfate as a Desensitizing Agent in Treatment of Lupus Erythematosus

Davidson, A. M.

doi:10.1001/archderm.1938.01480080080009

Cited by 19 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For almost a century, antimalarials have proven effective for the myriad of systemic and cutaneous manifestations associated with systemic lupus erythematosus (SLE) (3,8,9). Dubois (10) claimed that 90–95% of LE patients improved with HCQ compared to a 10% spontaneous remission rate.…”

Section: Clinical Studiesmentioning

confidence: 99%

Antimalarials

VanBeek

Piette

2001

Dermatol Ther

View full text Add to dashboard Cite

Over the last century, antimalarial medications have become the parenteral drugs of choice for treating the cutaneous manifestations of lupus erythematosus. The effects of immune modulation with the concomitant preservation of host immune response to exogenous antigens procures these agents as powerful tools in a wide range of conditions. With prudent dosage and monitoring, antimalarials can be used safely and effectively in the treatment and management of autoimmune connective tissue disease.

show abstract

Section: Clinical Studiesmentioning

confidence: 99%

Antimalarials

VanBeek

Piette

2001

Dermatol Ther

View full text Add to dashboard Cite

show abstract

Diseases Related to Light Sensitivity

Kesten¹

1953

Arch Dermatol

View full text Add to dashboard Cite

Treatment of Chronic Discoid Lupus Erythematosus With Chloroquine (Aralen)

Pillsbury¹

1954

JAMA

View full text Add to dashboard Cite

fluids was begun six hours postoperatively and continued at two hour intervals, always preceded by administration of pro¬ caine amide, 15 mg. in aqueous solution. No vomiting was present in the postoperative period, and procaine amide therapy was discontinued on the sixth postoperative day.Comment.-It is not unusual for an infant to vomit for a short time after pyloromyotomy because of the dis¬ turbed physiology in the operative area. The fact that all feedings were retained after the first dose of procaine amide strongly suggests that there was an element of residual spasm in the pyloric region and that it was re¬ lieved by therapy with the drug. The use of procaine amide solution in the postoperative management of in¬ fants undergoing pyloromyotomy is suggested by case 5. Cases 5 and 6 both illustrate that procaine amide therapy given in the presence of a pyloric tumor mass has no significant effect in the relief of vomiting. The immediate cessation of vomiting after pyloromyotomy and the ad¬ ministration of procaine amide indicated a complemen¬ tary effect of this antispasmodic. SUMMARYThe use of procaine amide (Pronestyl) in pylorospasm has not been previously reported. Its mode of action in the alleviation of spasm of the upper gastrointestinal tract is unknown. On the basis of our knowledge of the phar¬ macology of this drug, we postulate that its mode of action is due to anesthetization of the gastric mucosa that causes a diminution in local irritability and an elevation of thresholds to all gastrointestinal stimuli, a relaxation of the pyloric sphincter, and a quiescence of all gastro¬ intestinal motility. Investigations to test this hypothesis are in progress.The findings in these cases and the course of the infants described here suggests that procaine amide can play an important role in the alleviation of spasm in the upper gastrointestinal tract of infants. Four cases of pyloro¬ spasm in which marked improvement followed its use are presented. It did not appear to be of benefit in two cases of congenital hypertrophie pyloric stenosis in alleviating vomiting before pyloromyotomy. It seemed to be helpful in the postoperative management of these patients. It may prove to be an aid as a therapeutic test in pylorospasm. Further trial of procaine amide administered orally in pylorospasm in infants is suggested. It must be pointed out, however, that any child receiving procaine amide should be checked carefully for the various side-actions of this drug. Although these effects have not been ob¬ served, we have watched carefully for evidence of cardiac changes, central nervous system stimulation or depres¬ sion, and blood constituent changes. In another study on this drug,3 we saw minimal side-actions. In several pa¬ tients who have used procaine amide for periods over a year for arthritic pain, we have not seen changes. How¬ ever, too few cases have been reported for definite con¬ clusion to be reached. In an adult study to be reported at a later date, we found that gastric retention of various types have on ...

show abstract

Quinine Bisulfate as a Desensitizing Agent in Treatment of Lupus Erythematosus

Cited by 19 publications

References 0 publications

Antimalarials

Antimalarials

Diseases Related to Light Sensitivity

Treatment of Chronic Discoid Lupus Erythematosus With Chloroquine (Aralen)

Contact Info

Product

Resources

About